Gene information
Official symbol AHSG
Official full name alpha 2-HS glycoprotein
Gene type protein-coding gene
Chromosome3q27.3
Alias symbolFETUA; A2HS; HSGA
Gene familyCystatins, type 4
Resources
Entrez Gene 197
HGNC HGNC:349
Ensembl ENSG00000145192
Vega OTTHUMG00000156605
UCSC uc003fqk.5
GO terms: 36 records
GO Description Category LogP Number of genes Detail
GO:0001501 skeletal system development GO Biological Processes -17.2073293 69 More
GO:0001503 ossification GO Biological Processes -16.3087139 28 More
GO:0002526 acute inflammatory response GO Biological Processes -34.5980034 29 More
GO:0004857 enzyme inhibitor activity GO Molecular Functions -18.4005452 35 More
GO:0004866 endopeptidase inhibitor activity GO Molecular Functions -20.0646267 27 More
GO:0006897 endocytosis GO Biological Processes -8.07395492 24 More
GO:0006953 acute-phase response GO Biological Processes -24.9631834 19 More
GO:0006954 inflammatory response GO Biological Processes -86.5569367 100 More
GO:0010466 negative regulation of peptidase activity GO Biological Processes -24.1438543 35 More
GO:0010951 negative regulation of endopeptidase activity GO Biological Processes -24.7873219 35 More
GO:0030162 regulation of proteolysis GO Biological Processes -41.2267045 73 More
GO:0030278 regulation of ossification GO Biological Processes -11.2759455 26 More
GO:0030312 external encapsulating structure GO Cellular Components -73.3689453 93 More
GO:0030414 peptidase inhibitor activity GO Molecular Functions -19.6181890 27 More
GO:0030500 regulation of bone mineralization GO Biological Processes -10.1371537 13 More
GO:0031012 extracellular matrix GO Cellular Components -73.4416071 93 More
GO:0031091 platelet alpha granule GO Cellular Components -43.3287145 36 More
GO:0031093 platelet alpha granule lumen GO Cellular Components -40.0105787 31 More
GO:0031347 regulation of defense response GO Biological Processes -64.5971043 148 More
GO:0031983 vesicle lumen GO Cellular Components -60.5757669 68 More
GO:0034774 secretory granule lumen GO Cellular Components -58.3093741 66 More
GO:0043086 negative regulation of catalytic activity GO Biological Processes -41.1437610 130 More
GO:0045861 negative regulation of proteolysis GO Biological Processes -27.9905009 43 More
GO:0046626 regulation of insulin receptor signaling pathway GO Biological Processes -7.79385832 16 More
GO:0050727 regulation of inflammatory response GO Biological Processes -68.5964592 121 More
GO:0051346 negative regulation of hydrolase activity GO Biological Processes -26.0030636 42 More
GO:0052547 regulation of peptidase activity GO Biological Processes -35.5643317 55 More
GO:0052548 regulation of endopeptidase activity GO Biological Processes -34.9486589 53 More
GO:0060205 cytoplasmic vesicle lumen GO Cellular Components -59.3932782 67 More
GO:0060627 regulation of vesicle-mediated transport GO Biological Processes -25.1756709 46 More
GO:0061134 peptidase regulator activity GO Molecular Functions -19.3582235 29 More
GO:0061135 endopeptidase regulator activity GO Molecular Functions -19.1908633 27 More
GO:0062023 collagen-containing extracellular matrix GO Cellular Components -67.6170082 80 More
GO:0070167 regulation of biomineral tissue development GO Biological Processes -10.3239090 23 More
GO:0072562 blood microparticle GO Cellular Components -39.0217600 39 More
GO:0110149 regulation of biomineralization GO Biological Processes -10.9748263 24 More
Related studies: 13 records
Molecular factor Omics type Application Objective MI type Reference
alpha-2-HS-glycoprotein proteomics acute ST elevation myocardial infarction[diagnosis] acute ST elevation myocardial infarction Mathews ST et al. Clin Chim Acta. 2002
alpha-2-HS-glycoprotein proteomics myocardial infarction[diagnosis] myocardial infarction Weikert C et al. Circulation. 2008
alpha-2-HS-glycoprotein proteomics old ST elevation myocardial infarction[diagnosis] old ST elevation myocardial infarction Voros K et al. Eur J Clin Invest. 2011
alpha-2-HS-glycoprotein proteomics medium predictor death[prognosis (bad)] acute ST elevation myocardial infarction Basar N et al. J Investig Med. 2011
alpha-2-HS-glycoprotein proteomics ischemic postconditioning[treatment (other)] acute ST elevation myocardial infarction Liu SH et al. Clin Lab. 2013
alpha-2-HS-glycoprotein proteomics left ventricular remodeling[prognosis (bad)] acute ST elevation myocardial infarction Feistritzer HJ et al. Open Heart. 2015
alpha-2-HS-glycoprotein proteomics medium predictor acute myocardial infarction[diagnosis] acute myocardial infarction Schernthaner C et al. Eur J Clin Invest. 2017
alpha-2-HS-glycoprotein proteomics good predictor acute non-ST elevation myocardial infarction[diagnosis] acute non-ST elevation myocardial infarction Schernthaner C et al. Eur J Clin Invest. 2017
alpha-2-HS-glycoprotein proteomics poor predictor acute ST elevation myocardial infarction[diagnosis] acute ST elevation myocardial infarction Schernthaner C et al. Eur J Clin Invest. 2017
NM_001622.4:c.743T>C genomics myocardial infarction[diagnosis] myocardial infarction Fisher E et al. Circ Cardiovasc Genet. 2009
NM_001622.4:c.743T>C genomics myocardial infarction[diagnosis] myocardial infarction Coker-Gurkan A et al. Mol Med Rep. 2015
NM_001622.4:c.767G>C genomics obesity[other] old ST elevation myocardial infarction Temesszentandrasi G et al. Med Sci Monit. 2016
alpha-2-HS-glycoprotein proteomics medium predictor death[prognosis (bad)] ST elevation myocardial infarction Lim P et al. Clin Chem. 2007
All rights reserved: Soochow University Center for Systems Biology